For research use only. We do not sell to patients.
DB07107
CAS No. : 552332-71-5
Biological Activity：DB07107 is a potent drug resistant T315I mutant Bcr-Abl tyrosine kinase inhibitor. DB07107 is also a potent Akt1 inhibitor with an IC50 value of 360 nM[2].
Research Area：Cancer
Targets：Akt|Bcr-Abl
Related Small Molecules:Akt/NF-κB/JNK-IN-1;AT9283;Bafetinib;Cyclovirobuxine D;Pivanex;AKTide-2T;Sennidin A;SNIPER(ABL)-039;Flumatinib mesylate;IHMT-TRK-284;MS98;PP2A Cancerous-IN-1;1,3-Dicaffeoylquinic acid;Artemisiane E;SNIPER(ABL)-049;Olverembatinib;GNF-2;Artemisinin-d3;AS1949490;PI3K-IN-29;TD52 dihydrochloride;CT-721;SNIPER(ABL)-015;GNF-5;LM22B-10;AT13148;Pachymic acid;Glaucocalyxin A;PI3K/AKT-IN-2
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
